A recent study published in PubMed highlights the differing effects of two ABCB11 variants on patients with progressive familial intrahepatic cholestasis type 2. This research provides insights into the genetic underpinnings of the disease, which could inform future therapeutic strategies.
contrasting impacts of two abcb11 variants affecting the same residue in progressive familial intrahepatic cholestasis type 2
Original title: “Contrasting Impacts of Two ABCB11 Variants Affecting the Same Residue in Progressive Familial Intrahepatic Cholestasis Type 2.”